about
Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients.Targeted inhibition of the COP9 signalosome for treatment of cancerRationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bortezomib in the treatment of mantle cell lymphoma.
@en
type
label
Bortezomib in the treatment of mantle cell lymphoma.
@en
prefLabel
Bortezomib in the treatment of mantle cell lymphoma.
@en
P2860
P356
P1433
P1476
Bortezomib in the treatment of mantle cell lymphoma.
@en
P2093
Tadeusz Robak
P2860
P304
P356
10.2217/FON.15.191
P407
P577
2015-09-08T00:00:00Z